Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Brimonidine tartrate/Timolol 2mg/ml + 5mg/ml eye drops, solution

Active Ingredient:
ATC code: 
S01ED51
{info_black}
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 30 Oct 2025

Below is a text only representation of the Patient Information Leaflet (ePIL).

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on {phone} 0800 198 5000. The product code(s) for this leaflet is: PL 46130/0013.

Brimonidine tartrate/Timolol 2mg/ml + 5mg/ml eye drops, solution

Package leaflet: Information for the user

Brimonidine tartrate/Timolol 2mg/ml + 5mg/ml eye drops, solution

brimonidine tartrate/timolol

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet:

1. What Brimonidine/Timolol is and what it is used for
2. What you need to know before you use Brimonidine/Timolol
3. How to use Brimonidine/Timolol
4. Possible side effects
5. How to store Brimonidine/Timolol
6. Contents of the pack and other information

1 What Brimonidine/Timolol is and what it is used for

Brimonidine/Timolol is an eye drop that is used to control glaucoma. It contains two different medicines (brimonidine and timolol) that both reduce high pressure in the eye. Brimonidine belongs to a group of medicines called alpha-2 adrenergic receptor agonists. Timolol belongs to a group of medicines called beta blockers. Brimonidine/Timolol is prescribed to reduce high pressure in the eye when beta blocker eye drops used alone are not enough.

Your eye contains a clear, watery liquid that feeds the inside of the eye. Liquid is constantly being drained out of the eye and new liquid is made to replace this. If the liquid cannot drain out quickly enough, the pressure inside the eye builds up and could eventually damage your sight. Brimonidine/Timolol works by reducing the production of liquid and increasing the amount of liquid that is drained. This reduces the pressure inside the eye whilst still continuing to feed the eye.

2 What you need to know before you use Brimonidine/Timolol
Do not use Brimonidine/Timolol eye drops solution:
  • if you are allergic (hypersensitive) to brimonidine tartrate, timolol, beta blockers or any of the other ingredients of this medicine (listed in section 6). Symptoms of an allergic reaction may include swelling of the face, lips and throat, wheeziness, feeling faint, shortness of breath, itching or redness around the eye
  • if you have now or have had in the past respiratory problems such as asthma, severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing and/or long-standing cough)
  • if you have heart problems such as low heart rate, heart failure, heartbeat disorders (unless controlled by a pacemaker)
  • if you are taking monoamine oxidase (MAO) inhibitors or certain other antidepressant drugs.

Brimonidine/Timolol should not be used in children less than 2 years old and should not usually be used in children aged 2 to 17.

If you think any of these points apply to you, do not use Brimonidine/Timolol until you have talked again to your doctor.

Warnings and precautions

Talk to your doctor before using Brimonidine/Timolol

  • if you have now or have had in the past
    • coronary heart disease (symptoms can include chest pain or tightness, breathlessness or choking), heart failure, low blood pressure
    • disturbances of heart rate such as a slow heartbeat
    • breathing problems, asthma or chronic obstructive pulmonary disease
    • poor blood circulation disease (such as Raynaud’s disease or Raynaud’s syndrome)
    • diabetes as timolol may mask signs and symptoms of low blood sugar levels
    • over activity of the thyroid gland as timolol may mask signs and symptoms
    • kidney or liver problems
    • tumour of the adrenal gland
    • eye surgery to lower the pressure in your eye
  • if you suffer or have suffered from any allergy (e.g. hayfever, eczema) or a severe allergic reaction be aware that the usual dose of adrenaline used to control a severe reaction may need to be increased.

Tell the doctor before you have an operation that you are using Brimonidine/Timolol, as the timolol may change effects of some medicines during anaesthesia.

Other medicines and Brimonidine/Timolol

Brimonidine/Timolol can affect or be affected by other medicines you are using, including other eye drops for the treatment of glaucoma.

Tell your doctor or pharmacist if you are taking, have recently taken or might take other medicines, including medicines for any condition, even if unrelated to your eye condition, including medicines obtained without a prescription. There are a number of medicines which may interfere with Brimonidine/Timolol, so it is particularly important to tell your doctor if you are taking:

  • pain killers
  • medicines to help you sleep or for anxiety
  • medicines to treat high blood pressure (hypertension)
  • medicines for heart conditions (for example an abnormal heartbeat) such as beta blockers, digoxin or quinidine (used to treat heart conditions and some types of malaria)
  • medicines to treat diabetes or high blood sugar
  • medicines for depression such as fluoxetine and paroxetine
  • another eye drop used to lower high pressure in the eye (glaucoma)
  • medicines to treat severe allergic reactions
  • medicines that affect some of the hormones in your body, like adrenaline and dopamine
  • medicines that affect the muscles in your blood vessels
  • medicines to treat heartburn or stomach ulcers

If the dose of any of your current medicines is changed or if you are regularly consuming alcohol you should tell your doctor.

If you are due to have an anaesthetic, you should tell the doctor or dentist that you are taking Brimonidine/Timolol.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Do not use Brimonidine/Timolol if you are pregnant unless your doctor considers it necessary.

Do not use Brimonidine/Timolol if you are breast-feeding. Timolol may get into your milk. Ask your doctor for advice before taking any medicine during breast-feeding.

Driving and using machines

Brimonidine/Timolol may cause drowsiness, tiredness or blurred vision in some patients. Do not drive or use any tools or machines until the symptoms have cleared. If you experience any problems, talk to your doctor.

Important information about some of the ingredients of Brimonidine/Timolol

Contact Lenses

  • Do not use Brimonidine/Timolol while your contact lenses are in your eyes. Wait at least 15 minutes after using Brimonidine/Timolol before putting your lenses back in.
  • A preservative in Brimonidine/Timolol (benzalkonium chloride) may cause eye irritation and is also known to discolour soft contact lenses. See following paragraph.

Brimonidine/Timolol contains benzalkonium chloride

This medicine contains 0.05mg benzalkonium chloride in each ml of solution.

Benzalkonium chloride may be absorbed by soft contact lenses and may change the colour of the contact lenses. You should remove contact lenses before using this medicine and put them back 15 minutes afterwards.

Benzalkonium chloride may also cause eye irritation, especially if you have dry eyes or disorders of the cornea (the clear layer at the front of the eye). If you feel abnormal eye sensation, stinging or pain in the eye after using this medicine, talk to your doctor.

Brimonidine/Timolol contains phosphates

This medicine contains 10.58mg phosphates in each ml of solution, which is equivalent to 0.35mg per drop.

If you suffer from severe damage to the clear layer at the front of the eye (the cornea), phosphates may cause in very rare cases cloudy patches on the cornea due to calcium build-up during treatment.

3. How to use Brimonidine/Timolol

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Brimonidine/Timolol must not be used in infants below 2 years of age. Brimonidine/Timolol should not usually be used in children and adolescents (from 2 to 17 years).

The recommended dose is one drop of Brimonidine/Timolol, twice a day about 12 hours apart. Do not change the dose or stop taking it without speaking to your doctor.

If you have other eye drops as well as Brimonidine/Timolol, leave at least 5 minutes between using Brimonidine/Timolol and the other eye drops.

Instructions for use

You must not use the bottle if the tamper-evident ring on the bottle neck is broken before you first begin to use it.

1. Wash your hands and sit or stand comfortably.
2. Unscrew the cap.
3. Remove the tamper-evident ring from the bottle.
4. Tilt your head back and look at the ceiling.
5. Gently pull down the lower eyelid until there is a small pocket (Figure 1).
6. Turn the bottle upside down and squeeze it to release one drop into each eye that needs treatment (Figure 2).
7. Let go of the lower lid, and close your eye (Figure 3).
8. Keep the eye closed and press your finger against the corner of your eye (the side where your eye meets your nose) for two minutes (Figure 4). This helps stop Brimonidine/Timolol getting into the rest of the body.

If a drop misses your eye, try again.

To avoid contamination, do not let the tip of the bottle touch your eye or anything else. Put the screw-cap back on to close the bottle, straight after you have used it.

If you use more Brimonidine/Timolol than you should

Adults

If you use more Brimonidine/Timolol than you should, it is unlikely to cause you any harm. Put your next drop in at the usual time. If you are worried, talk to your doctor or pharmacist.

Babies and Children

Several cases of overdose have been reported in babies and children receiving brimonidine (one of the ingredients of Brimonidine/Timolol) as part of medical treatment for glaucoma. Signs include sleepiness, floppiness, low body temperature, paleness and breathing difficulties. Should this happen, contact your doctor immediately.

Adults and Children

If Brimonidine/Timolol has been accidentally swallowed then you should contact your doctor immediately.

If you forget to use Brimonidine/Timolol

If you forget to use Brimonidine/Timolol, use a single drop in each eye that needs treatment as soon as you remember, and then go back to your regular routine. Do not take a double dose to make up for a forgotten dose.

If you stop using Brimonidine/Timolol

Brimonidine/Timolol should be used every day to work properly.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4 Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience any of the following side effects, please contact your doctor immediately:

  • Heart failure (e.g. chest pain) or irregular heart rate
  • Increased or decreased heart rate or low blood pressure

Affecting the eye:

Very common (may affect more than 1 in 10 people):

  • Eye redness or burning

Common (may affect up to 1 in 10 people):

  • Stinging or pain in the eye
  • Allergic reaction in the eye or on the skin around the eye
  • Small breaks in the surface of the eye (with or without inflammation)
  • Swelling, redness or inflammation of the eyelid
  • Irritation, or a feeling of something in the eye
  • Itching of the eye and eyelid
  • Follicles or white spots on the see through layer which covers the surface of the eye
  • Vision disturbance
  • Tearing
  • Eye dryness
  • Sticky eyes

Uncommon (may affect up to 1 in 100 people):

  • Difficulty in seeing clearly
  • Swelling or inflammation of the see-through layer which covers the surface of the eye
  • Tired eyes
  • Sensitivity to light
  • Eyelid pain
  • Whitening of the see-through layer which covers the surface of the eyes
  • Swelling or areas of inflammation under the surface of the eye
  • Floaters in front of the eyes

Not known (frequency cannot be estimated from the available data):

  • Blurred vision

Affecting the body:

Common (may affect up to 1 in 10 people):

  • High blood pressure
  • Depression
  • Sleepiness
  • Headache
  • Dry mouth
  • General weakness

Uncommon (may affect up to 1 in 100 people):

  • Heart failure
  • Irregular heart rate
  • Light-headedness
  • Fainting
  • Dry nose
  • Taste disturbance
  • Nausea
  • Diarrhoea

Not known (frequency cannot be estimated from the available data):

  • Increased or decreased heart rate
  • Low blood pressure
  • Face redness

Some of these effects may be due to an allergy to any of the ingredients. Additional side effects have been seen with brimonidine or timolol and therefore may potentially occur with Brimonidine/Timolol.

The following additional side effects have been seen with brimonidine:

  • Inflammation within eye, small pupils, difficulty sleeping, cold-like symptoms, shortness of breath, symptoms involving the stomach and digestion, general allergic reactions, skin reactions including redness, face swelling, itching, rash and widening of blood vessels.

Like other medicines applied into eyes, Brimonidine/Timolol is absorbed into the blood. Absorption of timolol, a beta blocker component of this medicine, may cause similar side effects as seen with “intravenous” and/ or “oral” beta blocking agents. Incidence of side effects after topical ophthalmic administration is lower than when medicines, are for example, taken by mouth or injected. Listed side effects include reactions seen within the class of beta blockers when used for treating eye conditions:

  • Generalised allergic reactions, including swelling beneath the skin (that can occur in areas such as the face and limbs, and can obstruct the airway which may cause difficulty swallowing or breathing), hives (or itchy rash), localised and generalised rash, itchiness, severe sudden life threatening allergic reaction
  • Low-blood glucose levels
  • Difficulty in sleeping (insomnia), nightmares, memory loss
  • Stroke, reduced blood supply to the brain, increased signs and symptoms of myasthenia gravis (muscle disorder), unusual sensations (like pins and needles)
  • Inflammation in the cornea, detachment of the layer below the retina that contains blood vessels following filtration surgery which may cause visual disturbances, decreased corneal sensitivity, corneal erosion (damage to the front layer of the eyeball), drooping of the upper eyelid (making the eye half closed), double vision
  • Chest pain, oedema (fluid build up), changes in the rhythm or speed of the heartbeat, a type of heart rhythm disorder, heart attack, heart failure
  • Raynaud’s phenomenon, cold hands and feet
  • Constriction of the airways in the lung (predominantly in patients with pre-existing disease) difficulty breathing, cough
  • Indigestion, abdominal pain, vomiting
  • Hair loss, skin rash with white silvery coloured appearance (psoriasiform rash) or worsening of psoriasis, skin rash
  • Muscle pain not caused by exercise
  • Sexual dysfunction, decreased libido
  • Muscle weakness/tiredness

Other side effects reported with eye drops containing phosphates:

In very rare cases, some patients with severe damage to the clear layer at the front of the eye (the cornea) have developed cloudy patches on the cornea due to calcium build-up during treatment.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra. gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5 How to store Brimonidine/Timolol

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the bottle label and the carton after EXP. The expiry date refers to the last day of that month.

This medicinal product does not require any special temperature storage conditions, however the bottle should be kept in the outer carton.

You must throw away the bottle 28 days after you first opened it, even if there are still some drops left. This will help to prevent infections. To help you remember, write down the date that you opened it in the space on the carton.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6 Contents of the pack and other information
What Brimonidine/Timolol contains
  • The active substances are brimonidine tartrate and timolol.
  • One millilitre of solution contains 2 milligrams of brimonidine tartrate and timolol maleate equivalent to 5 milligrams of timolol (corresponding to 6.8mg timolol maleate).
  • The other ingredients are benzalkonium chloride (a preservative), sodium dihydrogen phosphate monohydrate, disodium hydrogen phosphate heptahydrate, hydrochloric acid (for pH adjustment), sodium hydroxide (for pH adjustment) and water for injections.

What Brimonidine/Timolol looks like and contents of the pack

Brimonidine/Timolol is a clear, greenish-yellow, particle free eye drop solution. It is available in a 10ml white plastic dropper bottle with a white screw cap and a tamper evident ring. Each bottle is about half full and contains 5ml of solution.

Packs are available containing 1 bottle.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Rafarm UK Limited
6th Floor
2 Kingdom Street
London
W2 6BD
UK

Manufacturer

Rafarm S.A.
Thesi Pousi-Xatzi
Agiou Louka
19002
Paiania Attiki
Greece

Distributor

Aspire Pharma Ltd
Unit 4
Rotherbrook Court
Bedford Road
Petersfield
Hampshire
GU32 3QG
UK

This leaflet was last revised in 07/2024

1010627 - P2.3

Aspire Pharma Ltd
Company image
Address
4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK
Telephone
+44 (0)1730 231148
Medical Information Direct Line
+44 (0)1730 231148
Customer Care direct line
+44 (0)1730 231148